Institute for Medical BioMathematics (IMBM)

What Institute for Medical BioMathematics (IMBM) does

The Institute for Medical BioMathematics (IMBM) is a non-profit organization founded in 1999 and headquartered at imbm.org. With a current headcount of approximately 9 employees, IMBM is a very small entity operating in the intersection of mathematics and medicine, as suggested by its name. The available source material does not detail specific research programs, publications, products, or service offerings beyond what the organization's name implies. No leadership team, partnerships, customer roster, or funding history is disclosed in the input data, and the organization's website content consists of a loading/verification page with no substantive company information. The operating status, active research areas, and current institutional activity cannot be confirmed from the supplied evidence.

The organization's revenue model, pricing, and go-to-market approach are not disclosed. No customer segments, select customers, marketing channels, distribution channels, or value proposition details are available in the source material. Certifications, regulatory actions, patents, awards, subsidiaries, mergers and acquisitions, and corporate structural moves are all absent from the data. Given the non-profit designation and the bio-mathematics focus implied by the name, plausible operating models would include grant-funded research, contract research for pharmaceutical or medical device sponsors, or academic collaboration, but none of these are explicitly confirmed by the input.

For investment analysis purposes, the data set supports only a minimal characterization of IMBM: a small, long-standing non-profit with a website and roughly nine employees. Any further characterization of products, customers, revenue mechanics, or strategic activity would require primary research beyond the supplied sources.

Name

Institute for Medical BioMathematics (IMBM)

Website

https://imbm.org

Company type

Private

Headcount range

1–10 employees

Short description

The Institute for Medical BioMathematics (IMBM) is a non-profit founded in 1999 with approximately 9 employees, focused on the intersection of mathematics and medicine. Its specific research programs, products, customers, and funding sources are not disclosed in the available source data.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA)

Keywords

• Biomathematical modeling
• Medical research services
• Biostatistics consulting
• Clinical data analysis
• Quantitative biology research

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Others

Core offering

IMBM is a non-profit research institute that performs mathematical, statistical, and computational modeling work to support biomedical and clinical research. Its services are delivered to life sciences organizations and research collaborators seeking rigorous quantitative analysis of medical and biological problems.

Differentiator

Problem solved

Functional benefit

Products and services

• Biomathematical research and modeling services Application of mathematical and computational modeling techniques to biomedical and clinical research problems, delivered to pharmaceutical, biotech, and academic research clients.
• Biostatistics and clinical data analysis consulting Statistical analysis and quantitative consulting on clinical and biological datasets for medical research organizations and academic collaborators.

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Entelos (operating as Rosa subsidiary): Originally a leading biosimulation firm, now absorbed into Rosa & Co., representing historical direct competition in mathematical biosimulation for drug development.
• Numerus: Provides biostatistics and statistical modeling consulting for biomedical research, representing a smaller-scale, partially overlapping quantitative-biology services peer.

Broad incumbents

• Simulation Plus: Provides model-based drug development software and services spanning PBPK, pharmacometrics, and quantitative systems pharmacology — a much larger, established commercial player in a closely adjacent mathematical-biology space.
• SRI International: An established non-profit contract research organization with biosciences and health research programs — comparable non-profit R&D structure spanning computational biology and translational research.
• The Jackson Laboratory: A large, established non-profit biomedical research organization with quantitative and computational biology programs — a structurally similar non-profit research institution at much greater scale.
• Certara: A leading public technology and services platform for model-informed drug development, biosimulation, and regulatory science — overlapping heavily with IMBM's mathematical-biology remit but at vastly larger scale.

Direct peers

• Metrum Research Group: Provides pharmacometric, statistical, and quantitative pharmacology services to pharma and biotech, applying mathematical modeling to drug development — closely aligned with IMBM's medical bio-mathematics focus.
• Physiomics plc: Applies mathematical modeling and systems biology to support oncology drug development, offering comparable mathematical-biology consulting to pharma sponsors.
• Rosa & Co. Specializes in mechanistic physiological modeling and computational biology for pharmaceutical R&D, mirroring IMBM's mathematical-modeling approach to biological systems.

Others

• Mathematical Biosciences Institute: An academic research institute focused on mathematical and computational methods in the biological sciences — comparable as a peer research organization rather than a commercial competitor.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/institute-for-medical-biomathematics-imbm-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Medical BioMathematics (IMBM)